In an unrated note published in a question and answer format on Dec 14, PhillipCapital’s research team spoke to Biolidics on the company’s recent developments on its SARS-CoV-2 Antigen Rapid Test Kit and other Covid-19 test kits.

In March 2020, the Singapore-based medical technology company launched its IgC/IgM antibody test kit for Covid-19. 

On Nov 26, the company announced that it entered into a distribution agreement with Chinese biotech company JOYSBIO for its antigen rapid test kits for Covid-19 (called Colloidal Gold).

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook